62.75 0.00 (0.00%)
After hours: 4:32PM EST
Previous Close | 63.01 |
Open | 62.79 |
Bid | 62.68 x 800 |
Ask | 62.76 x 800 |
Day's Range | 62.18 - 63.32 |
52 Week Range | 56.56 - 85.97 |
Volume | 6,801,383 |
Avg. Volume | 8,975,643 |
Market Cap | 78.851B |
Beta (5Y Monthly) | 0.43 |
PE Ratio (TTM) | 640.31 |
EPS (TTM) | 0.10 |
Earnings Date | Apr 28, 2021 - May 03, 2021 |
Forward Dividend & Yield | 2.84 (4.51%) |
Ex-Dividend Date | Mar 12, 2021 |
1y Target Est | 74.54 |
Dr. Heather Yeo, SurvivorNet Medical Advisor & Associate Professor of Surgery and Associate Professor of Population Health Sciences at New York Presbyterian Weill Cornell Medicine, joins Yahoo Finance’s Kristin Myers to discuss the latest coronavirus updates.
Sales of Gilead’s Covid-19 antiviral remdesivir could reach $3 billion this year. An analyst says the company should try the cat version of the drug on humans to make revenues from Covid-19 antivirals last.
Diodes Incorporated (Nasdaq: DIOD), today announced Brett Whitmire, Chief Financial Officer; Emily Yang, Sr. Vice President of Worldwide Sales and Marketing; and Laura Mehrl, Director of Investor Relations, will participate in the Loop Capital Markets Virtual Consumer, Industrials & TMT Conference on Thursday, March 11, 2021. Management will be available throughout the day to host conference calls with investors participating in the event.